Neurogene Inc (NGNE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
11.00 +2.03 (+22.63%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 11.00 unch (unch) 16:00 ET
for Fri, Apr 11th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,144 | -36,317 | -55,189 | -60,692 | -33,277 |
| Depreciation Amortization | 828 | 3,192 | 3,200 | 2,277 | 1,821 |
| Accounts payable and accrued liabilities | -77 | 667 | -3,607 | N/A | N/A |
| Other Working Capital | -5,961 | -4,023 | -2,695 | -700 | 966 |
| Other Operating Activity | 9,751 | -14,941 | 5,467 | 11,557 | 5,915 |
| Operating Cash Flow | $-70,603 | $-51,422 | $-52,824 | $-47,558 | $-24,575 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -808 | -321 | -2,230 | -3,263 | -2,219 |
| Purchase Of Investment | -198,453 | N/A | N/A | 0 | N/A |
| Sale Of Investment | 74,000 | 5,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 20,958 | 0 | 0 | 0 |
| Investing Cash Flow | $-125,261 | $25,637 | $-2,230 | $-3,263 | $-2,219 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 92,343 | N/A | N/A | N/A |
| Debt Repayment | -52 | -29 | -1 | -51 | -49 |
| Common Stock Issued | 191,265 | 168 | 73 | 783 | 77,539 |
| Other Financing Activity | -7,142 | 0 | 66,459 | 0 | -355 |
| Financing Cash Flow | $184,071 | $92,482 | $66,531 | $732 | $77,135 |
| Beginning Cash Position | 148,718 | 82,021 | 70,544 | 193,434 | 143,093 |
| End Cash Position | 136,925 | 148,718 | 82,021 | 143,345 | 193,434 |
| Net Cash Flow | $-11,793 | $66,697 | $11,477 | $-50,089 | $50,341 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,603 | -51,422 | -52,824 | -47,558 | -24,575 |
| Capital Expenditure | -808 | -321 | -2,230 | -3,263 | -2,219 |
| Free Cash Flow | -71,411 | -51,743 | -55,054 | -50,821 | -26,794 |